Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
1,417
datasets available to search
ShareScore release 0.9.0
Dataset results
1,417 results for “triple negative breast cancer”
A Study of BL-B01D1+PD-1 Monoclonal Antibody in Patients With Unresectable Locally Advanced or Recurrent Metastatic Triple-negative Breast Cancer
ClinicalTrials.gov study NCT06471205. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Prospective, Open-label, Single-arm, Exploratory Clinical Trial to Evaluate the Safety and Tolerability of 225Ac-TR2205 Injection in Patients With Triple-negative Breast Cancer.
ClinicalTrials.gov study NCT07340424. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Peri-Operative Immune Checkpoint Inhibition and Cryoablation in Women With Triple-negative Breast Cancer
ClinicalTrials.gov study NCT03546686. IPD Sharing: Not stated. Countries: 1. Publications: 0.
All Trans Retinoic Acid Combined with Toripalimab+Chemotherapy for Locally Advanced Inoperable or Metastatic Triple Negative Breast Cancer：a Multi-center, Multi-cohort Phase II Trial
ClinicalTrials.gov study NCT06636981. IPD Sharing: NO. Countries: 1. Publications: 0.
Triple-negative Breast Cancer: a New Perspective on Biomarkers
ClinicalTrials.gov study NCT03539965. IPD Sharing: NO. Countries: 1. Publications: 0.
Efficacy and Safety of Extended-Dose Interval Immunotherapy Versus Standard-Dose Interval Immunotherapy for Advanced Triple-Negative Breast Cancer
ClinicalTrials.gov study NCT07401537. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Biomarkers of Efficacy and Tolerability of Sacituzumab-Govitecan in the Treatment of Patients With Triple-negative Breast Cancer in the Metastatic Phase: Prospective Multicenter Real-world Study
ClinicalTrials.gov study NCT06240195. IPD Sharing: NO. Countries: 1. Publications: 0.
Safety and Tolerability of Everolimus in Combination With Eribulin in Triple-negative Breast Cancers
ClinicalTrials.gov study NCT02616848. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Neoadjuvant Dupilumab, Pembrolizumab, Paclitaxel, and Carboplatin in Locally Advanced Triple Negative Breast Cancer
ClinicalTrials.gov study NCT06637306. IPD Sharing: YES. Countries: 1. Publications: 0.
A Study of HX008 for the Treatment of Patients With Metastatic Triple Negative Breast Cancer
ClinicalTrials.gov study NCT04750382. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Adjuvant Treatment for High-risk Triple Negative Breast Cancer Patients With the Anti-PD-l1 Antibody Avelumab
ClinicalTrials.gov study NCT02926196. IPD Sharing: Not stated. Countries: 2. Publications: 0.
Stereotactic Body Radiation Therapy Combined With Anti-PD-1 Antibody in Metastatic Triple Negative Breast Cancer
ClinicalTrials.gov study NCT03151447. IPD Sharing: NO. Countries: 1. Publications: 0.
A Study of SKB264 Versus Investigator's Choice Chemotherapy in Patients With Unresectable Recurrent or Metastatic Triple-Negative Breast Cancer
ClinicalTrials.gov study NCT06279364. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study to Evaluate the Efficacy and Safety of SG001 in Combination With Nab-Paclitaxel in Patients With Advanced Triple-Negative Breast Cancer (TNBC)
ClinicalTrials.gov study NCT05068141. IPD Sharing: Not stated. Countries: 1. Publications: 0.
EGFR/B7H3 CAR-T on Lung Cancer and Triple Negative Breast Cancer
ClinicalTrials.gov study NCT05341492. IPD Sharing: NO. Countries: 1. Publications: 0.
Tiragolumab, Atezolizumab and Chemotherapy in Triple Negative Breast Cancer
ClinicalTrials.gov study NCT06175390. IPD Sharing: YES. Countries: 1. Publications: 0.
INCMGA00012 and Pelareorep for the Treatment of Metastatic Triple Negative Breast Cancer, IRENE Study
ClinicalTrials.gov study NCT04445844. IPD Sharing: YES. Countries: 1. Publications: 0.
Triple Negative Breast Cancer: Study of Molecular and Genetic Factors
ClinicalTrials.gov study NCT01434420. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ProAgio in Combination With Gemcitabine in Patients With Metastatic Triple Negative Breast Cancer
ClinicalTrials.gov study NCT06460298. IPD Sharing: NO. Countries: 1. Publications: 0.
Comparison Between ER Loss and Triple-Negative Breast Cancer Guided by 18F-FES PET/CT in Metastatic Breast Cancer
ClinicalTrials.gov study NCT07316439. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.